RCKT (Rocket Pharmaceuticals, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by RCKT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-20 | Gaurav Shah | CEO | Sell | — | — |
| 2026-08-20 | Martin Wilson | General Counsel | Sell | — | — |
| 2026-08-17 | Martin Wilson | General Counsel | Sell | — | — |
| 2026-08-17 | Gaurav Shah | CEO | Sell | — | — |
| 2026-08-13 | Sarbani Chaudhuri | See Remarks | Sell | — | — |
| 2026-08-13 | Christopher James Stevens | Chief Operating Officer | Sell | — | — |
| 2026-08-05 | Christopher James Stevens | Chief Operating Officer | A | — | — |
| 2026-08-05 | DAVID P SOUTHWELL | Director | J | — | — |
| 2026-07-06 | Mikael Dolsten | Director | A | — | — |
| 2026-07-06 | Fady Ibraham Malik | Director | A | — | — |
| 2026-07-06 | CARSTEN BOESS | Director | A | — | — |
| 2026-07-06 | Peter Fong | Director | A | — | — |
| 2026-07-06 | DAVID P SOUTHWELL | Director | A | — | — |
| 2026-07-06 | RODERICK WONG | Director | A | — | — |
| 2023-02-22 | John Militello | See Remarks | M | — | — |
| 2023-02-22 | Gaurav Shah | CEO | Sell | — | — |
| 2023-02-22 | Gaurav Shah | CEO | M | — | — |
| 2023-02-22 | Jonathan David Schwartz | See Remarks | M | — | — |
| 2023-02-22 | John Militello | See Remarks | Sell | — | — |
| 2023-02-22 | Kinnari Patel | See Remarks | M | — | — |
| 2023-02-22 | Jonathan David Schwartz | See Remarks | Sell | — | — |
| 2023-02-16 | John Militello | See Remarks | A | — | — |
| 2023-02-16 | Jonathan David Schwartz | See Remarks | A | — | — |
| 2023-02-16 | Kinnari Patel | See Remarks | A | — | — |
| 2023-02-16 | Martin Wilson | General Counsel | A | — | — |
| 2023-02-16 | Gaurav Shah | CEO | A | — | — |
| 2022-12-23 | RODERICK WONG | Director | J | — | — |
| 2022-12-22 | RTW INVESTMENTS, LP | Director | J | — | — |
| 2022-10-11 | RODERICK WONG | Director | Buy | — | — |
| 2022-08-16 | John Militello | See Remarks | A | — | — |
| 2022-08-16 | Martin Wilson | General Counsel | A | — | — |
| 2022-08-16 | Kinnari Patel | See Remarks | A | — | — |
| 2022-08-16 | Jonathan David Schwartz | See Remarks | A | — | — |
| 2022-06-15 | Naveen Yalamanchi | Director | A | — | — |
| 2022-06-15 | Fady Ibraham Malik | Director | A | — | — |
| 2022-06-15 | DAVID P SOUTHWELL | Director | A | — | — |
| 2022-06-15 | Elisabeth Bjork | Director | A | — | — |
| 2022-06-15 | Gotham Makker | Director | A | — | — |
| 2022-06-15 | RODERICK WONG | Director | A | — | — |
| 2022-06-15 | CARSTEN BOESS | Director | A | — | — |
| 2022-06-15 | PEDRO P GRANADILLO | Director | A | — | — |
| 2022-04-20 | John Militello | See Remarks | A | — | — |
| 2022-04-04 | Jonathan David Schwartz | See Remarks | Sell | — | — |
| 2022-04-01 | Jonathan David Schwartz | See Remarks | Sell | — | — |
| 2022-03-11 | Fady Ibraham Malik | Director | A | — | — |
| 2022-03-09 | Gotham Makker | Director | G | — | — |
| 2022-02-16 | Carlos Garcia-Parada | Chief Financial Officer | A | — | — |
| 2022-02-16 | Jonathan David Schwartz | See Remarks | A | — | — |
| 2022-02-16 | Kinnari Patel | See Remarks | A | — | — |
| 2022-02-16 | Gaurav Shah | CEO | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 18,263,956 | — |
| — | Director | 16,272,635 | — |
| — | Director | 16,185,119 | — |
| — | CEO | 1,254,935 | — |
| — | Director | 674,901 | — |
| — | General Counsel | 673,853 | — |
| — | Chief Operating Officer | 505,784 | — |
| — | Director | 317,646 | — |
| — | See Remarks | 262,809 | — |
| — | See Remarks | 173,241 | — |
| — | See Remarks | 94,546 | — |
| — | Director | 76,195 | — |
| — | Director | 67,082 | — |
| — | Director | 52,862 | — |
| — | Director | 52,862 | — |
| — | See Remarks | 1,614 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the RCKT quote page; the site-wide leaderboard is on the insider transactions hub.